Bargain hunters are advised to monitor insider buying patterns, as they often indicate positive future expectations. Recently, Elanco Animal Health’s CEO, Lawrence Erik Kurzius, purchased 10,000 shares of ELAN at $21.30 each, totaling $213,000. As of today, the stock has risen approximately 6.4% to a high of $22.67. Previously, Kurzius acquired shares worth $211,000 at $10.55 each within the last year.
In a separate transaction, Prabu Natarajan, CFO of Science Applications International, bought 2,000 shares at $100.49 each for a total investment of $200,976 on Tuesday. Natarajan’s earlier purchase within the past year involved $219,098 worth of shares at $109.55 each. Science Applications International’s stock has increased by about 2.4% today.
